Cell line · CVCL_D603
FreeStyle 293-F
Transformed cell line, Homo sapiens. 93 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. FreeStyle 293-F. Cell lines, record CVCL_D603. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_D603
On this page
Cell line
As Cellosaurus gives it.
- Name
- FreeStyle 293-F
- Accession
- CVCL_D603
- RRID
- RRID:CVCL_D603
- Synonyms
- Freestyle-293F, FreeStyle 293F, Freestyle 293F, FreeStyle293-F, FreeStyle293F, FreeStyle 293, Freestyle 293, FreeStyle293, Freestyle HEK293F, 293-F FreeStyle, FS-293F
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- Fetus
- Category
- Transformed cell line
- Derived from
- Fetal kidney (in situ)
- Parent
- HEK293-F (CVCL_6642)
- Entry created
- 2012-10-22
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers93
12 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Development and characterization of a long-acting allosteric growth hormone receptor antagonist for acromegaly. | Endocrinology | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer. | J Clin Invest | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Wnt-induced conformational phospho-switch in DVL3 controls association with Frizzled receptors and Wnt/β-catenin signaling. | Sci Adv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Precision-Engineered DC-Targeting mRNA-LNP Neoantigen Vaccine Elicits Stronger T Cell Responses and Exhibits Superior Tumor Control. | Vaccines (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Identification and characterization of bone marrow plasma cells producing IFN-γ-neutralizing autoantibodies in adult-onset immunodeficiency. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Antagonist nanobodies prevent protease inhibition by CD109. | J Biol Chem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Function-driven design of a surrogate interleukin-2 receptor ligand. | FEBS Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| IgG-Bridging-Seeded Synergistic Aggregation of SARS-CoV-2 Spikes Underlies Potent Neutralization by a Low-Affinity Antibody. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The fc fragment of IgMs binds C1q to activate the first step of the classical complement pathway, while inhibiting complement-dependent cytotoxicity. | FEBS J | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 93
See all 93 papersRelatives8
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | HEK293-F | CVCL_6642 | Cell lines | |
| Derived from it | CellSensor C/EBP-bla FreeStyle 293F | CVCL_KS66 | Cell lines | |
| Derived from it | CellSensor CRE-bla FreeStyle 293F | CVCL_KS56 | Cell lines | |
| Derived from it | CellSensor LEF/TCF-bla FreeStyle 293F | CVCL_KS02 | Cell lines | |
| Derived from it | CellSensor NFAT-bla Freestyle 293F | CVCL_XA24 | Cell lines | |
| Derived from it | CellSensor NFkB-bla Freestyle 293F | CVCL_KB48 | Cell lines | |
| Derived from it | HEK-293-F TIMP-2-EK-6XHis | CVCL_E8D9 | Cell lines | |
| Derived from it | HEK-293-F coTIMP-2-6XHis | CVCL_E8D8 | Cell lines |
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_D603
GET https://conductscience.org/api/cell-lines/v1/CVCL_D603/papers?page=2